Status:
COMPLETED
Ocular Findings in Women With Primary Antiphospholipid Syndrome
Lead Sponsor:
Cairo University
Conditions:
Primary Antiphospholipid Syndrome
Eligibility:
FEMALE
18-35 years
Brief Summary
Antiphospholipid antibody syndrome (APS) is an autoimmune disease characterized by systemic thrombosis and bad obstetric history. APS secondary to another medical disorder is the most common. Visual a...
Eligibility Criteria
Inclusion
- Age: 18 to 35 years
- Females with primary antiphospholipid syndrome
Exclusion
- Age: below 18 years and above 35 years
- Auto-immune diseases e.g. SLE and other connective tissue disease
- Medical diseases causing retinal vascular changes e.g. hypertension, diabetes mellitus, sickle cell anemia.
- Previous vitreo-retinal surgery
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 23 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03459508
Start Date
December 1 2017
End Date
October 23 2018
Last Update
October 24 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt